CLINICAL_TRIALS
research
· 2026-04-07
Clinical Trial Update: VivaStent Feasibility Study [NA]
Summary
A feasibility trial of VivaStent for pulsatile tinnitus is planned, with recruitment not yet started.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: V-Flow 21 | Conditions: Pulsatile Tinnitus | NA | Status: NOT_YET_RECRUITING